These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 14337707

  • 1. SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. 3. IDENTIFICATION OF SERINE AS THE SITE OF SULFONYLATION IN PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN.
    GOLD AM.
    Biochemistry; 1965 May; 4():897-901. PubMed ID: 14337707
    [No Abstract] [Full Text] [Related]

  • 2. SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. II. FORMATION AND REACTIONS OF PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN.
    GOLD AM, FAHRNEY D.
    Biochemistry; 1964 Jun; 3():783-91. PubMed ID: 14211616
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of "serine" esterases by phenylarsonic acids. alpha-chymotrypsin and the subtilisins.
    Glazer AN.
    J Biol Chem; 1968 Jul 10; 243(13):3693-701. PubMed ID: 4968801
    [No Abstract] [Full Text] [Related]

  • 4. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar 10; 11(2):241-5. PubMed ID: 5654209
    [No Abstract] [Full Text] [Related]

  • 5. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jan 10; 12(1):118-22. PubMed ID: 5763006
    [No Abstract] [Full Text] [Related]

  • 6. 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin.
    Koehler KA, Lienhard GE.
    Biochemistry; 1971 Jun 22; 10(13):2477-83. PubMed ID: 5557796
    [No Abstract] [Full Text] [Related]

  • 7. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar 22; 11(2):233-41. PubMed ID: 5654208
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap.
    Brouwer AJ, Ceylan T, Jonker AM, van der Linden T, Liskamp RM.
    Bioorg Med Chem; 2011 Apr 01; 19(7):2397-406. PubMed ID: 21421320
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of alpha-chymotrypsin by a water-soluble carbodiimide.
    Banks TE, Blossey BK, Shafer JA.
    J Biol Chem; 1969 Dec 10; 244(23):6323-33. PubMed ID: 5354958
    [No Abstract] [Full Text] [Related]

  • 10. Selective inhibition of serine proteases by alkyldimethylbenzylammonium chloride.
    Feldbau E, Schwabe C.
    Biochemistry; 1971 May 25; 10(11):2131-8. PubMed ID: 5562832
    [No Abstract] [Full Text] [Related]

  • 11. Methylation of histidine-57 in alpha-chymotrypsin by methyl p-nitrobenzenesulfonate. A new approach to enzyme modification.
    Nakagawa Y, Bender ML.
    Biochemistry; 1970 Jan 20; 9(2):259-67. PubMed ID: 5460940
    [No Abstract] [Full Text] [Related]

  • 12. Sedimentation of chemically modified chymotrypsin.
    Neet KE, Brydon SE.
    Arch Biochem Biophys; 1970 Jan 20; 136(1):223-7. PubMed ID: 5417619
    [No Abstract] [Full Text] [Related]

  • 13. VARIATION OF THE CONFORMATION OF THE ACTIVE SITE OF ALPHA-CHYMOTRYPSIN WITH HYDROGEN ION CONCENTRATION.
    PLATT A, NIEMANN C.
    Proc Natl Acad Sci U S A; 1963 Nov 20; 50(5):817-21. PubMed ID: 14082345
    [No Abstract] [Full Text] [Related]

  • 14. Thermodynamics of alpha-chymotrypsin-substrate and inhibitor complex formation as a function of pH. Hydrophobic binding by the low and high pH forms of the enzyme.
    Cuppett CC, Canady WJ.
    J Biol Chem; 1970 Mar 10; 245(5):1069-74. PubMed ID: 5417260
    [No Abstract] [Full Text] [Related]

  • 15. The stereospecificity of alpha-chymotrypsin.
    Ingles DW, Knowles JR.
    Biochem J; 1968 Jul 10; 108(4):561-9. PubMed ID: 5667268
    [Abstract] [Full Text] [Related]

  • 16. CHARACTERIZATION OF A REVERSIBLY FORMED ENZYME COMPLEX IN THE REACTION OF CHYMOTRYPSIN WITH DIISOPROPYL FLUOROPHOSPHATE.
    MOON AY, MERCOUROFF J, HESS GP.
    J Biol Chem; 1965 Feb 10; 240():717-21. PubMed ID: 14275126
    [No Abstract] [Full Text] [Related]

  • 17. INTERACTION OF AROMATIC COMPOUNDS WITH ALPHA-CHYMOTRYPSIN.
    WALLACE RA, KURTZ AN, NIEMANN C.
    Biochemistry; 1963 Feb 10; 2():824-36. PubMed ID: 14075122
    [No Abstract] [Full Text] [Related]

  • 18. [The chemoselective fluorescence labeling of alpha-chymotrypsin].
    Horner L, Flemming HW.
    Biol Chem Hoppe Seyler; 1985 Mar 10; 366(3):303-10. PubMed ID: 3924074
    [Abstract] [Full Text] [Related]

  • 19. Prototropic equilibrium of the reaction of diisopropylphosphofluoridate with alpha-chymotrypsin.
    Marini MA, Martin CJ.
    Biochim Biophys Acta; 1968 Sep 10; 168(1):73-8. PubMed ID: 5684631
    [No Abstract] [Full Text] [Related]

  • 20. FORMAMIDINE SULFINIC ACID AS A BIOCHEMICAL REDUCING AGENT.
    SHASHOUA VE.
    Biochemistry; 1964 Nov 10; 3():1719-20. PubMed ID: 14235337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.